ATC N01AX14 · Other General Anesthetics · updated 2 Nov 2026

Esketamine shortage

As of 2 Nov 2026, Esketamine has a reported shortage in 1 of the 16 countries we track (Norway), covering 1 product from 1 company.

Is there an Esketamine shortage?

Yes. As of 2 Nov 2026, Esketamine is reported short in 1 of the 16 countries we track: Norway. The earliest expected return is 8 Jan 2027 (Norway).

Countries1/16

Products1packs or presentations

Companies11 listed

Short since–

Earliest return8 Jan 2027company estimate

Main reasonDistribution or logistics

Which companies are short

products short, all countries

Listed: Pfizer PFE · NYSE

Compared with similar medicines

ATC group N01AX · Other General Anesthetics

Affected products

Country	Product	Company	Since	Expected back	Reason
NO	Ketanest 25 mg/ml injeksjons-/infusjonsvæske, oppløsning, 10 x 2 ml ampulle anticipated	PFIZER AS	7 Dec 2026	8 Jan 2027	Distribution or logistics Distribusjonsproblemer

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there an Esketamine shortage?

Yes. As of 2 Nov 2026, Esketamine is reported short in 1 of the 16 countries we track: Norway. The earliest expected return is 8 Jan 2027 (Norway).

When will Esketamine be back in stock?

Companies expect supply back from 8 Jan 2027 in Norway; Norway: 8 Jan 2027. These are company estimates reported to each authority.

Why is Esketamine in short supply?

The most common reason reported is: distribution or logistics. Reasons by product are listed in the table below.

Which companies have Esketamine shortages?

Pfizer.